Sign inJoin waitlistJoin the waitlist

David Adams

PROFESSOR AND SYSTEM CHAIR · Icahn School of Medicine at Mount Sinai

Credentials: · · · ·

History

Icahn School of Medicine at Mount Sinai
Present
Cardiovascular Surgery Department · Icahn School of Medicine at Mount Sinai
Present
Icahn School of Medicine at Mount Sinai
Present

Thoracic Surgery
1983–1989
Duke University School of Medicine
1979–1983

Research

Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients
New England Journal of Medicine · 2019 · 3,033 citations
Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for…
Review · Journal of the American Society of Echocardiography · 2017 · 2,983 citations
Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients
New England Journal of Medicine · 2017 · 2,399 citations

FF
Farzan Filsoufi
79 papers · 14 as a resident
Anelechi Anyanwu
74 papers · 5 as a fellow
Joanna Chikwe
56 papers · 23 as a resident
Michael Reardon
49 papers
LC
Lawrence Cohn
46 papers
Jeffrey Popma
41 papers
AE
Ahmed El-Eshmawi
32 papers · 10 as a resident
Shinobu Itagaki
32 papers
Sary Aranki
30 papers
Gilbert Tang
29 papers
Gregory Couper
29 papers
G Deeb
27 papers

Clinical trials

TRILUMINATE Pivotal Trial
Principal investigator · Active not recruiting
Abbott Medical Devices
2019–2029
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Principal investigator · Recruiting
Medtronic Cardiovascular
2017–2036
Safety & Efficacy Study of the Medtronic CoreValve® System-Treatment of Symptomatic Severe Aortic Stenosis With Significant Comorbidities in Extreme Risk Subjects Who Need Aortic Valve Replacement
Principal investigator · Completed
Medtronic Cardiovascular
2012–2025
Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI).
Principal investigator · Active not recruiting
Medtronic Cardiovascular
2012–2026